News | April 20, 2015

Joan Lunden among advocates calling for increased screening access, parity of insurance coverage for treatment options

Komen, advocates, breast cancer, Congress, Joan Lunden, Brinker, Salerno

Nancy G. Brinker (left), founder and chair of global strategy for Susan G. Komen breast cancer survivor and former \"Good Morning America\" host Joan Lunden (center) and Komen President and CEO Judy Salerno, M.D., (right) at the Komen Advocacy Summit. Photo courtesy of Business Wire.


April 20, 2015 — Members of the Susan G. Komen Foundation took to the nation’s capitol April 16 to advocate for the importance of access to cancer screening programs. The group also called on policy makers to ensure parity of insurance coverage between oral chemotherapy and traditional IV treatments.   

Among the group was breast cancer survivor and former “Good Morning America” host Joan Lunden. Lunden, who was diagnosed with triple negative breast cancer last summer, met with members of her home state of Connecticut — including U.S. Sen. Chris Murphy and Rep. Rosa DeLauro — to talk about her experience with breast cancer. She stressed the importance of women knowing about breast density, and pushing to have a secondary screening if they have dense breast tissue, an action that found her breast cancer after receiving a clean mammogram.

Komen advocates from its community Affiliate Network visited 360 offices in both the House and Senate to push for maintaining the government’s commitment to vital safety net programs, such as the National Breast and Cervical Cancer Early Detection Program. They also discussed the importance of ensuring parity between the way insurance covers oral chemotherapy, which often is governed by prescription drug benefit rules, and traditional IV treatments, which often have lower co-pays.

“Everything we do is aimed at ending this disease, and helping the millions of people who need us, every single day,” said Judith A. Salerno, M.D., M.S., Komen’s president and CEO, noting that Komen is also encouraging increases for biomedical research funding. “The fact is that biomedical research funding has dropped by 25 percent in real dollar terms over the past 10 years and we run the risk that medical research will stall. We urge the federal government to increase this important funding.”

The Summit kicked off with a dinner that featured remarks from Lunden, who discussed how her diagnosis has inspired her to educate other women. She was joined by Salerno and Nancy Brinker, Susan G. Komen founder and chair of global strategy. The week ended with a lunch featuring a talk from singer and songwriter Nikia Hammonds-Blakely, a breast cancer survivor who was diagnosed with the disease when she was 16 years old.

For more information: www.komen.org


Related Content

News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | RSNA 2025

Nov. 3, 2025 — QT Imaging Holdings has announced that its chief medical officer, Elaine luanow, MD, will host a seminar ...

Time November 04, 2025
arrow
News | Breast Imaging

Oct. 28, 2025 — QT Imaging Holdings, Inc., a medical device company focused on radiation-free imaging technology, has ...

Time October 28, 2025
arrow
Subscribe Now